GPCR

β‐Arrestin-Biased Agonists of the GLP‐1 Receptor from β‐Amino Acid Residue Incorporation into GLP‐1 Analogues

Backbone modification of a polypeptide drug alters duration of action in vivo

Receptor selectivity from minimal backbone modification of a polypeptide agonist